Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen (5mg/300mg, 7.5mg/300mg and 10mg/300mg).
Subscribe to our email newsletter
The company has also announced the launch of the treatment for the relief of moderate to moderately severe pain, Hydrocodone Bitartrate and Acetaminophen.
Boca Pharmacal, a research and development company, claims that it’s Hydrocodone Bitartrate and Acetaminophen is the generic version of Victory Pharma’s Xodol.
Xodol is indicated for the relief of moderate to moderately severe pain and combines the efficacy of hydrocodone with the lowest dose of acetaminophen available of the commonly prescribed hydrocodone/acetaminophen combination products.